We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




DNA Sequencing Technologies Help Diagnosis of Salmonella typhi

By Labmedica staff writers
Posted on 04 Aug 2008
Researchers have used next-generation DNA sequencing technologies to type Salmonella typhi (Salmonella enterica serotype Typhi, elevated to species status as S. More...
typhi), identify the strain that causes infection, identify carriers, and direct vaccination programs more efficiently. This will help to improve diagnosis, tracking of disease spread, and possibly the design of new strategies for vaccination.

Unlike most related Salmonella species, and in contrast to many other bacteria, S. typhi is found only in humans and the genomes of all isolates are superficially extremely similar, hampering attempts to track infections or to type more prevalent variants. There are 17 million cases of typhoid fever each year--although the World Health Organization (WHO; Geneva, Switzerland; www.who.org) cautions that this is a "very conservative” estimate. Young people are most at risk: in Indonesia, 9 out of 10 cases occur in 3 to 19-year-olds.

A team of researchers at the Wellcome Trust Sanger Institute (Cambridge, UK), University College, Cork (UCC; UK), Institut Pasteur (Paris, France), and Oxford University Clinical Research Unit (Ho Chi Minh City, Vietnam) studied 19 isolates of Typhi from 10 countries, using new sequencing methods in order to capture the rare signals of genetic variation in the genome. They produced more than 1.7 billion letters of genetic sequence and found evidence of fewer than 2000 mutation events, suggesting very little evolution since the emergence of Typhi at least 15,000 years ago.

The team developed methods that are being used to type outbreaks, allowing identification of individual organisms that are spreading in the population "A key to survival of S. typhi is its ability to lie dormant in carriers, who show no symptoms but remain able to infect others,” said Kathryn Holt, a Ph.D. student at the Wellcome Trust Sanger Institute. "Our new tools will assist us in tracing the source of typhoid outbreaks, potentially even to infected carriers, allowing those individuals to be treated to prevent further spread of the disease.”

The study was reported in the June 27, 2008, issue of the journal Nature Genetics.


Related Links:
Wellcome Trust Sanger Institute
University College, Cork
World Health Organization

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.